75 results
Page 2 of 4
SC 14D9
2obt33s3b2jin32nt1a
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
ruycp06x0uijkp353n
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-99.1
ns0bkdr2yjmxa6dq1
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
60rpevf51y06qlm9vsie
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
y8chv0jnn2 uzlnebio
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
yg33e
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
8-K
EX-99.1
latomdv6
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
cssjyhv
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
dt4rvwwbcmwrsaeazqn
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
1wqwapg
3 Jan 22
Other Events
6:03am
8-K
rhxt1tg
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
q29uc
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
cz7zua
8 Dec 21
Regulation FD Disclosure
6:55am
8-K
EX-99.3
76ua o1mv
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.2
zd6wf0 s18
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.1
ekmwr2tkp6gpp7l
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am